Shiv Desai, MD
Radiation Oncology · Orlando, FLNPI 1730523176
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Ambu Inc. at 34.2% of the total. Reporting peaked in 2022 at $3,175 and has fallen 60.3% since, to $1,261 in 2025.
Across 108 payments — averaging $75.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ambu Inc.$3K
- Brainlab, Inc.$1K
- Siemens Medical Solutions USA, Inc.$952
- Regeneron Healthcare Solutions, Inc.$550
- Novocure Inc.$336
- Bayer$317
- plus $2K from 18 others
What the payments were for
- Consulting fees$2,40029%
- Travel & lodging$1,35517%
- Food & beverage$4,42154%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ambu Inc. | 8 | $2,793 |
| Brainlab, Inc. | 13 | $1,478 |
| Siemens Medical Solutions USA, Inc. | 10 | $952 |
| Regeneron Healthcare Solutions, Inc. | 12 | $550 |
| Novocure Inc. | 13 | $336 |
| Bayer | 13 | $317 |
| Mevion_medical_systems_inc | 2 | $293 |
| AstraZeneca | 5 | $216 |
| Reflexion Medical, Inc. | 2 | $197 |
| Bioprotect Medical, Inc. | 2 | $162 |
| GT Medical Technologies, Inc | 3 | $160 |
| Galvanize Therapeutics, Inc | 1 | $103 |
| GE HealthCare | 2 | $102 |
| Myriad Genetic Laboratories, Inc. | 5 | $101 |
| Elekta, Inc. | 3 | $99 |
| Viewray Technologies Inc | 3 | $98 |
| Boston Scientific | 3 | $51 |
| Novartis | 2 | $41 |
| Blue Earth Diagnostics | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $24 |
| Merck | 1 | $21 |
| Pfizer | 1 | $21 |
| Teleflex LLC | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,176 in reported general payments places this provider in the 85th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $796 |
| Dexamethasone | 48 | $779 |
| Memantine Hcl | 30 | $362 |
| Sucralfate | 11 | $328 |
| Tamsulosin Hcl | 14 | $115 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $107 |
| Lorazepam | 17 | $40 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Orlando
- Shravan KandulaOrlando$444K
- Ravi ShridharOrlando$192K
- Akash NandaOrlando$165K
- Imran MohiuddinOrlando$93K
- Charles HodgeOrlando$34K
- Bridget KoontzOrlando$26K
- Justin RineerOrlando$11K
- Matthew BiagioliOrlando$10K
- Nina JohnsonOrlando$7K
- Martin KeischMiami Shores$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.